Sami M Bahlas
Overview
Explore the profile of Sami M Bahlas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alghamdi M, Bahlas S, Alamry S, Mattar E, Redwan E
Antibodies (Basel)
. 2025 Feb;
14(1).
PMID: 39982225
Background: Autoantibodies such as rheumatoid factor (RF) and anticitrullinated protein autoantibodies (ACPAs) are useful tools for rheumatoid arthritis (RA). The presence of ACPAs against citrullinated proteins (CPs), especially citrullinated fibrinogen...
2.
Al-Jedai A, Almudaiheem H, Al-Homood I, Almaghlouth I, Bahlas S, Alolaiw A, et al.
Curr Rheumatol Rev
. 2024 May;
PMID: 38693734
Objective: To provide evidence-based clinical practice recommendations for managing Systemic Lupus Erythematosus (SLE) in Saudi Arabia. Methods: This EULAR-adapted national guideline in which a multidisciplinary task force utilized the modified...
3.
Alagha A, Bahlas S, Alariefy A, Alqarni S, Almahyawi F, Alariefy S
Cureus
. 2024 Feb;
16(1):e51929.
PMID: 38333483
Background The immune system, composed of various molecules and cells, protects humans from cancer and pathogens. A breach of tolerance, known as autoimmune disease (AD), is the root of these...
4.
Almalag H, Al Juffali L, Alshehri M, Altokhais N, Aljanobi G, Dessougi M, et al.
J Multidiscip Healthc
. 2023 Nov;
16:3455-3463.
PMID: 38024119
Introduction: Multidisciplinary setting in healthcare provide positive patient outcomes. Objective: To evaluate the impact of specialized rheumatology clinics (multidisciplinary settings) on the activation and engagement of rheumatoid arthritis (RA) patients....
5.
Almalag H, Alshehri M, Altokhais N, Aljanobi G, Dessougi M, AlHarthi A, et al.
Immun Inflamm Dis
. 2023 Nov;
11(11):e1101.
PMID: 38018573
Objectives: To evaluate patient activation in rheumatoid arthritis (RA) patients using patient activation measure 13 (PAM-13) on a national level in Saudi Arabia. Method: A national survey was administered across...
6.
Omair M, Alshehri M, Altokhais N, Aljanobi G, Dessougi M, AlHarthi A, et al.
Patient Prefer Adherence
. 2022 May;
16:1105-1114.
PMID: 35502428
Purpose: Compliance is essential to achieve treatment goals in rheumatoid arthritis (RA) patients. The current study evaluated compliance and related factors in a large and diverse population. Patients And Methods:...
7.
Alghamdi M, Alamry S, Bahlas S, Uversky V, Redwan E
Cell Mol Life Sci
. 2021 Dec;
79(1):25.
PMID: 34971426
Circulating extracellular vesicles (EVs) are membrane-bound nanoparticles secreted by most cells for intracellular communication and transportation of biomolecules. EVs carry proteins, lipids, nucleic acids, and receptors that are involved in...
8.
Amir A, Khader S, El Chami Z, Bahlas S, Bakir M, Arifeen S
J Family Community Med
. 2021 Oct;
28(3):155-163.
PMID: 34703375
We report existing evidence and gaps in neuropathic pain management in Saudi Arabia, the prevalence and patient management stages in diabetic peripheral neuropathy (DPN) and low back pain (LBP) with...
9.
Khoja S, El-Miedany Y, Iyer A, Bahlas S, Balamash K, Elshal M
Clin Lab
. 2018 Feb;
64(1):51-58.
PMID: 29479872
Background: The aim of this study is to evaluate the prevalence of vitamin-D insufficiency and vitamin-D receptor (VDR) polymorphisms in rheumatoid arthritis (RA) patients and its association with disease activity...
10.
Khoja S, Miedany Y, Iyer A, Bahlas S, Balamash K, Elshal M
Clin Lab
. 2017 Dec;
63(11):1841-1849.
PMID: 29226640
Background: Patients with rheumatoid arthritis (RA) have significantly increased cardiovascular (CV) morbidity and mortality that are not accounted for by traditional risk factors alone. Paraoxonase 1 (PON1) and 25-hydroxyvitamin D...